RECRUITING

Wellness Program Outreach and Effectiveness

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellness and disease-management programs have the potential to improve wellbeing and reduce healthcare costs, their effectiveness is often undermined by low engagement and selection bias in participant comparisons. This study will test whether an outreach approach that auto-enrolls eligible individuals-employees and their spouses/domestic partners-into the program, with the option to opt out, can increase engagement and improve health outcomes compared to the standard invitation-based approach.

Official Title

Wellness Program Outreach and Effectiveness: A Randomized Controlled Trial

Quick Facts

Study Start:2024-10-02
Study Completion:2026-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06725511

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Provided informed consent.
  2. 2. Those who are eligible for the Pack Health program:
  3. * Employees/spouses/domestic partners over the age of 18
  4. * Metabolic syndrome defined as results indicating 3 or more of the following risk factors:
  5. * High waist circumference (\>35 inches for women and \>40 inches for men)
  6. * High triglycerides (≥150 mg/dl)
  7. * Low HDL cholesterol (\<50 mg/dl for women and \<40 mg/dl for men)
  8. * High Blood Pressure (≥130/85)
  9. * High Fasting Glucose (≥100 mg/dl)
  1. * 1. Anyone under the age of 21. They will not be part of the study and will receive messages as if they were in the control group.
  2. 2. Anyone observed in claims data with a historical diagnosis of:
  3. * Anorexia nervosa
  4. * Bulimia nervosa
  5. * Binge-eating disorder
  6. * Body dysmorphic disorder
  7. * Major depression
  8. * Post-traumatic stress disorder (PTSD)
  9. * Severe anxiety disorder

Contacts and Locations

Study Contact

Joseph Doyle, PhD
CONTACT
6174523761
jjdoyle@mit.edu
David Molitor, PhD
CONTACT
2172440504
dmolitor@illinois.edu

Principal Investigator

Joseph Doyle, PhD
PRINCIPAL_INVESTIGATOR
MIT Sloan School of Management

Study Locations (Sites)

Quest Diagnostics
Secaucus, New Jersey, 07094
United States

Collaborators and Investigators

Sponsor: Massachusetts Institute of Technology

  • Joseph Doyle, PhD, PRINCIPAL_INVESTIGATOR, MIT Sloan School of Management

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-02
Study Completion Date2026-08-31

Study Record Updates

Study Start Date2024-10-02
Study Completion Date2026-08-31

Terms related to this study

Keywords Provided by Researchers

  • Metabolic Syndrome
  • Workplace wellness

Additional Relevant MeSH Terms

  • Metabolic Syndrome